Bristol Myers Squibb expands Nvidia partnership to supercharge its AI drug factory
Covered by 1 source · 2 articles
Bristol Myers Squibb acquires Nvidia's Vera Rubin DGX SuperPOD for drug discovery, becoming the first pharma company to deploy the latest AI computing The post Bristol Myers Squibb buys Nvidia’s latest AI computing system for drug research…
All coverage
Bristol Myers Squibb buys Nvidia’s latest AI computing system for drug research
Bristol Myers Squibb acquires Nvidia's Vera Rubin DGX SuperPOD for drug discovery, becoming the first pharma company to deploy the latest AI computing The post Bristol Myers Squibb buys Nvidia’s latest AI computing system for drug research…
Bristol Myers Squibb expands Nvidia partnership to supercharge its AI drug factory
Bristol Myers Squibb expands its Nvidia AI factory partnership, reporting 55% cost savings on drug discovery workloads. Here's what it means for investors. The post Bristol Myers Squibb expands Nvidia partnership to supercharge its AI drug…